GoodRx Holdings (GDRX) Deferred Taxes (2019 - 2026)

GoodRx Holdings has disclosed Deferred Taxes across 8 years of filings, most recently posting $4.1 million for Q1 2026.

• Deferred Taxes for Q1 2026 came in at $4.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $4.8 million (up 140.11% YoY), and the FY2025 annual result was $20.1 million, up 268.47% from the prior year.
• Deferred Taxes came in at $4.1 million for Q1 2026 at GoodRx Holdings, down from $12.0 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $12.0 million in Q4 2025 to a low of -$63.0 million in Q2 2023.
• The 5-year median for Deferred Taxes is -$160500.0 (2022), against an average of -$5.2 million.
• Peak annual rise in Deferred Taxes reached 2459.49% in 2023, while the deepest fall reached 108746.55% in 2023.
• GoodRx Holdings' Deferred Taxes stood at -$356000.0 in 2022, then plunged by 2027.25% to -$7.6 million in 2023, then sank by 48.84% to -$11.3 million in 2024, then soared by 206.3% to $12.0 million in 2025, then sank by 66.04% to $4.1 million in 2026.
• The last three Deferred Taxes figures came in at $4.1 million (Q1 2026), $12.0 million (Q4 2025), and -$11.3 million (Q4 2024), per Business Quant data.